breakingview  astrazeneca’ messag warrant  review 
london reuter breakingview  astrazeneca’ vaccin home run   danger  turn   curvebal  134 billion drug giant  plan  review  covid19 vaccin candid  clarifi  effect    ’    uk group  probabl   separ review    commun
